The PEGylated Proteins Market is primarily driven by the growing demand for effective drug delivery systems, particularly in the treatment of chronic diseases such as cancer, hepatitis, and rheumatoid ...
2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...
Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab, AstraZeneca’s benralizumab, Amgen Inc ...
Zacks.com on MSN2d
AstraZeneca Beats on Q3 Earnings, Ups 2024 View, to Invest $3.5B in USAmgen records product sales in the United States and AstraZeneca ... which included alliance revenues mentioned earlier as ...
The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...
The companies did not provide detailed data for Tezspire, however, and William Blair’s Matt Phipps said in a note he does not ...
A Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...
AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback